Loading…

Readressing the Role of Toll-Like Receptor-4 Alleles in Inflammatory Bowel Disease: Colitis, Smoking, and Seroreactivity

Background Toll-like receptor ( TLR ) polymorphisms, and especially TLR - 4 Asp299Gly and TLR - 4 Thr399Ile , have been linked with Crohn’s disease (CD) and to a lesser extent with ulcerative colitis (UC), CD behavior, and compromised seroreactivity to microbial antigens. Available data, however, ar...

Full description

Saved in:
Bibliographic Details
Published in:Digestive diseases and sciences 2013-02, Vol.58 (2), p.371-380
Main Authors: Manolakis, Anastassios C., Kapsoritakis, Andreas N., Kapsoritaki, Anastasia, Tiaka, Elisavet K., Oikonomou, Konstantinos A., Lotis, Vassilis, Vamvakopoulou, Dimitra, Davidi, Ioanna, Vamvakopoulos, Nikolaos, Potamianos, Spyros P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Toll-like receptor ( TLR ) polymorphisms, and especially TLR - 4 Asp299Gly and TLR - 4 Thr399Ile , have been linked with Crohn’s disease (CD) and to a lesser extent with ulcerative colitis (UC), CD behavior, and compromised seroreactivity to microbial antigens. Available data, however, are conflicting. Aims To address these issues, the distribution of TLR - 4 polymorphic alleles was assessed in patients with UC, CD, and healthy controls (HC), considering patient and disease characteristics as well as related serological markers. Methods TLR - 4 Asp299Gly and TLR - 4 Thr399Ile polymorphisms were determined in 187 UC and 163 CD patients and 274 randomly selected HC. C reactive protein, anti- Saccharomyces cerevisiae mannan antibodies, anti-mannobioside carbohydrate antibodies, anti-laminariobioside carbohydrate antibodies IgG, and anti-chitobioside carbohydrate antibodies (ACCA) IgA levels were also assessed. Results UC and especially pancolitis patients carried the mutant alleles more frequently compared to CD patients and HC or UC patients with different disease extents ( P  = 0.002 and P  
ISSN:0163-2116
1573-2568
DOI:10.1007/s10620-012-2348-4